Pharmaceuticals

In the last 12 hours

Exelixis’ cancer drug wins approval for neuroendocrine tumors ENDPOINTS18:38 26-Mar-25

Royal College of Pharmacy plan gets go-ahead after RPS member vote Hospital Pharmacy Europe17:09 26-Mar-25

ATyr hires ex-ChemoCentryx commercial chief for planned launch FiercePharma17:08 26-Mar-25

Adalimumab Biosimilars Show Similar Outcomes in Psoriasis After Nonmedical Switch Center for Biosimilars16:28 26-Mar-25

Psilocybin: How Science Is Turning Magic Mushrooms Into Medicine IFLScience16:17 26-Mar-25

view more headlines

In the last 24 hours

Insiders Make Huge Purchases of These 4 Biotech Stocks 24/7 Wall St.12:50 26-Mar-25

Analysis-Trump turbulence stalls large pharma and biotech deals, bankers say KELO TV11:04 26-Mar-25

End of the line for Cassava's troubled Alzheimer's programme pharmaphorum11:01 26-Mar-25

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income The Motley Fool10:35 26-Mar-25

2 No-Brainer Growth Stocks to Buy and Hold Forever The Motley Fool10:14 26-Mar-25

Trump tariffs would increase biopharma costs — industry survey ENDPOINTS10:09 26-Mar-25

Men going bald turn to 'new Botox' for hair loss treatment Fox News09:27 26-Mar-25

Is Novo Nordisk Stock a Buy? The Motley Fool09:13 26-Mar-25

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib (Revised) Zacks08:00 26-Mar-25

Ambroxol - the next big hope Rory Cellan-Jones07:56 26-Mar-25

Cardiff company targets US expansion following record-breaking sales growth Wales 24706:59 26-Mar-25

view more headlines

In the last 48 hours

GSK scores FDA approval for new UTI antibiotic ENDPOINTS17:03 25-Mar-25

Axsome’s Scores In ADHD, But Differentiation In Generic-Heavy Market Unclear Scrip Pharma Intelligence21:17 25-Mar-25

Lyndra Therapeutics to shut down after funding challenges ENDPOINTS20:47 25-Mar-25

Senate committee backs Dr. Oz for CMS nomination ENDPOINTS19:36 25-Mar-25

Illumina adds activist investor to board, taps ex-FDA head as chair ENDPOINTS18:45 25-Mar-25

US Approves GSK’s New Antibiotic for Urinary Tract Infections Bloomberg Law17:51 25-Mar-25

Calculating healthcare's real costs ENDPOINTS17:24 25-Mar-25

RFK Jr. reportedly plans to ban pharmaceutical ads on TV FOX13 Seattle16:12 25-Mar-25

FDA starts review of Sanofi's MS hope tolebrutinib pharmaphorum13:00 25-Mar-25

Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drug KELO TV12:49 25-Mar-25

Character Biosciences raises $93M with an eye on vision loss drugs BioPharma Dive12:15 25-Mar-25

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib Zacks12:09 25-Mar-25

Hillstar Bio raises $67M for immunology drugs ENDPOINTS10:36 25-Mar-25

view more headlines

In the last 4 days

EMA Accepts GSK's Filing for Expanded Use of Nucala in COPD Zacks19:02 24-Mar-25

Dr Reddys announces cessation of subsidiary in Louisiana The Business Standard08:48 24-Mar-25

Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics PharmTech.com20:50 24-Mar-25

FDA Update: Current Guidelines for Semaglutide and Tirzepatide Compounding JD Supra18:02 24-Mar-25

German pharma giant Bayer must pay US cancer patient almost €2bn Brussels Signal15:15 24-Mar-25

23andMe files for bankruptcy protection pharmaphorum09:53 24-Mar-25

U.S. Senator makes super suspicious healthcare stock trade Finance in Bold18:44 23-Mar-25

Scientists Say New Drug Could Help Prevent Alzheimer’s Greek Reporter13:04 23-Mar-25

With Fabhalta’s C3G Approval, Now Novartis Has To Find The Patients Scrip Pharma Intelligence21:43 24-Mar-25

In a $2B deal, Novo licenses obesity drug from China’s United Bio BioWorld21:41 24-Mar-25

Novo Nordisk inks $2-billion obesity drug deal with United Labs The Economic Times19:45 24-Mar-25

FDA's biologics chief stresses need for vaccine transmission data ENDPOINTS18:40 24-Mar-25

Best Practices and Guidelines in Immunoglobulin Therapy Pharmacy Times15:56 24-Mar-25

Two biotechs fail to beat or match Regeneron's Eylea in key trials ENDPOINTS15:38 24-Mar-25

AstraZeneca and GKS shares have legs, but the weight loss titans will dominate, says investment … Proactive Investors (UK)14:35 24-Mar-25

Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge FiercePharma14:27 24-Mar-25

Beyond The Drive-Thru: Ensuring Patient Access Across Specialty Distribution Systems and Non-Formulary Coverage Pharmacy Times13:13 24-Mar-25

SAP overtakes Novo Nordisk to become Europe’s largest company Financial Mail12:54 24-Mar-25

Exclusive: Mira Pharmaceuticals Signs To Acquire Skny Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking… Benzinga11:28 24-Mar-25

Novo Nordisk secures license to weight-loss drug candidate from China's United Labs KELO TV11:20 24-Mar-25

AstraZeneca CEO: Chinese government support for us uncommon elsewhere CGTN08:42 24-Mar-25

GSK says European regulator reviewing expanded use of asthma drug Nucala KELO TV07:56 24-Mar-25

Singapore gives nod to GSK's Omjjara (momelotinib) as first treatment indicated for myelofibrosis patients with anaemia BioSpectrum Asia07:42 24-Mar-25

view more headlines

In the last 7 days

Novartis shares positive phase 3 results for spinal muscular atrophy gene therapy PMLiVE12:24 20-Mar-25

Johnson & Johnson plans $55 billion in US investments over the next four years Yahoo! UK & Ireland11:45 21-Mar-25

Paratek to acquire Optinose and its nasal spray Xhance ENDPOINTS11:10 20-Mar-25

Johnson & Johnson is the latest pharma giant to court Trump with new investment plans Quartz18:51 21-Mar-25

A closer look at pharma’s top patent losses in 2025 FiercePharma13:10 21-Mar-25

Dren draws $600M up front from Sanofi in $1.9B antibody deal BioWorld20:56 20-Mar-25

Bharat Biotech launches India's only integrated cell, gene therapy, and viral production… AniNews.in17:52 20-Mar-25

Chiesi bails on TiumBio’s $75 mil. respiratory drug deal as biotech pivots to cancer and reproductive health Korea Biomedical Review09:35 20-Mar-25

Sanofi to acquire Dren Bio's immunology unit Yahoo! UK & Ireland06:47 20-Mar-25

Astra, J&J and Others Say UK ‘Uninvestable’ Amid Drug Rebate Row Bloomberg Law05:45 20-Mar-25

Novartis Urges Court To Make FDA Block Entresto Generic Law36000:56 22-Mar-25

Stelara Biosimilars Storm US Market With 85% Discounts Ahead Of Price Drop In Medicare Scrip Pharma Intelligence22:00 21-Mar-25

New SEC Leadership Signals Continued Focus on FDA-Related Disclosures JD Supra22:00 21-Mar-25

FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again FiercePharma19:28 21-Mar-25

Scotland's first Head of AI in Medicine appointed at Aberdeen The University of Aberdeen15:53 21-Mar-25

FDA approves Novartis’ Fabhalta for C3 glomerulopathy treatment Pharmaceutical Business Review11:07 21-Mar-25

This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used … Business Insider10:18 21-Mar-25

J&J plans to invest more than $55 billion in US over next four years Yahoo! US10:11 21-Mar-25

Wegovy: The obesity ‘wonderdrug’ comes to Ireland, but it will cost you The Irish Times05:09 21-Mar-25

Bharat Biotech forays into cell and gene therapy with $75 million vertically integrated CGT,… The Times of India01:10 21-Mar-25

Akero exec calls MASH accelerated approval guidance 'bizarre' ENDPOINTS19:49 20-Mar-25

Sanofi Advances Immunology Ambitions With Dren Deal Scrip Pharma Intelligence16:19 20-Mar-25

Clinical trial begins for therapeutic innovation for respiratory infections Clinical Services Journal15:46 20-Mar-25

Paratek acquires Optinose, rhinosinusitis spray Xhance in deal worth up to $330M FiercePharma15:29 20-Mar-25

Sapio Sciences integrates NVIDIA BioNeMo for AI-driven drug discovery European Pharmaceutical Manufacturer15:15 20-Mar-25

view more headlines

In the last 14 days

FDA Recalls Acne Treatments Over Carcinogen Prevention.com16:26 17-Mar-25

Novartis plots 427 layoffs in New Jersey as looming Entresto patent cliff sparks marketing… FiercePharma14:25 18-Mar-25

£10,000 invested in AstraZeneca shares 1 year ago is now worth… Motley Fool (UK)13:12 19-Mar-25

This Unstoppable Biotech Stock Just Became an Even Better Buy The Motley Fool13:07 19-Mar-25

Amgen Keeps Win Over Regeneron Bid to Block Eylea Biosimilar Bloomberg Law15:31 14-Mar-25

NFL signs Novartis as first pharmaceutical partner-source KELO TV12:34 13-Mar-25

Amgen reports more Phase 3 Uplizna data in myasthenia gravis ahead of FDA filing ENDPOINTS11:23 13-Mar-25

Trump accuses Ireland of ‘stealing’ U.S. pharma industry amid tax dispute EurActiv.com17:37 13-Mar-25

Pfizer sells remaining Haleon shares in £170m deal Insider Media08:21 19-Mar-25

IRA round 2 begins as drugmakers sign on to price negotiation process with CMS FiercePharma15:47 18-Mar-25

Combination immunotherapy improves treatment response for head and neck cancer News-Medical.Net18:48 13-Mar-25

Pembrolizumab in Combination With Platinum-, Fluoropyrimidine-Based Chemotherapy Receives FDA Approval for GEJ Pharmacy Times19:06 19-Mar-25

Now Vivek Ramaswamy wants to rename a body of water The Independent15:41 18-Mar-25

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million The Business Standard07:50 18-Mar-25

FDA Accepts Priority Review for Finerenone New Indication to Include Patients With Heart Failure Pharmacy Times18:05 17-Mar-25

Eventful Monday For AstraZeneca - What's Going On? Benzinga12:19 17-Mar-25

Should You Try Melatonin to Help You Sleep? Yale Medicine23:33 14-Mar-25

FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns JD Supra18:19 13-Mar-25

I asked ChatGPT to name 5 UK stocks for a perfectly balanced ISA – here’s what it picked Motley Fool (UK)16:01 13-Mar-25

Propranolol vs. Metoprolol: How Do They Compare as Beta-Blockers? Very Well Health14:35 13-Mar-25

Lotte Biologics signs MOU with Asimov to strengthen CDMO business Korea Biomedical Review06:39 13-Mar-25

Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma The Times of India03:51 13-Mar-25

Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake This is Money22:12 19-Mar-25

Medtronic recalls aneurysm-treating devices linked to four deaths Lexington Herald-Leader, Kentucky21:10 19-Mar-25

Brentuximab Vedotin Combo Adds Another Targeted Option Beyond CD19/CD20 in R/R LBCL OncLive19:18 19-Mar-25

view more headlines

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.